The phrases "best electrolyte supplement" and "top hydration packets" are used in this report to reflect common consumer search behavior in 2026. This analysis does not rank products, verify outcomes, ...

About the FALCON Trial FALCON is a first-in-human, open-label, multi-center Phase 1b clinical trial designed to evaluate the safety and tolerability of SGT-212 in participants aged 18-40 who have been ...

The Company expects to provide further information regarding its full year 2026 financial guidance on its fourth quarter earnings call in February.

NEW HYDE PARK, N.Y., Jan. 12, 2026 (GLOBE NEWSWIRE) -- CareMed ®, an independent specialty pharmacy, has been selected as a pharmacy partner by Cytokinetics for MYQORZO™ ( aficamten ), indicated for ...

Precision Neuroscience Corporation (Precision) today announced a strategic partnership with Medtronic to advance neurosurgery, leveraging Precision’s brain–computer interface (BCI) technology and ...

Glo & Spa-rkle Aesthetics and Medical Spa, a leading name in aesthetic and wellness services, is thrilled to announce its relocation to a brand new, state-of-the-art facility in Lubbock, Texas. The ...

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on January 10, 2026, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an ...

The preliminary, unaudited revenue results and cash, cash equivalents and financial assets described in this press release are estimates only and are subject to revision until Nyxoah reports its full ...

A live webcast of the fireside chat can be found here and on the investor relations section of the Company’s website at https://investors.genelux.com/. Following the live webcast, an archived replay ...

SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a company engaged in clinical-stage pharmaceutical developments through its majority-owned subsidiary NeuroThera Labs Inc., announced today that ...

- Rapid increase in diagnosis of ADH1 with >1,700 unique patients identified since October 2023; BridgeBio intends to submit an NDA to the FDA based on results from CALIBRATE, the Company’s Phase 3 ...

New York, USA, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Sorevna, a company in the cosmetics industry, today announced its planned entry into the bath and body care segment, expanding its existing product ...